These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38367635)
1. Rapid evolution of pan-β-lactam resistance in Enterobacterales co-producing KPC and NDM: insights from global genomic analysis after the COVID-19 pandemic. Sellera FP; Lincopan N; Fuentes-Castillo D; Stehling EG; Furlan JPR Lancet Microbe; 2024 May; 5(5):e412-e413. PubMed ID: 38367635 [No Abstract] [Full Text] [Related]
2. NDM-1-producing strains, family Enterobacteriaceae, in hospital, Beijing, China. Zhou G; Guo S; Luo Y; Ye L; Song Y; Sun G; Guo L; Chen Y; Han L; Yang J Emerg Infect Dis; 2014 Feb; 20(2):340-2. PubMed ID: 24456600 [No Abstract] [Full Text] [Related]
3. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future? Oteo J; Miró E; Pérez-Vázquez M; Navarro F Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048 [TBL] [Abstract][Full Text] [Related]
4. Proceedings of the ESCMID Conference on Extended-spectrum Beta-lactamases. Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():1-202. PubMed ID: 18376442 [No Abstract] [Full Text] [Related]
5. KPC and NDM-1 genes in related Enterobacteriaceae strains and plasmids from Pakistan and the United States. Pesesky MW; Hussain T; Wallace M; Wang B; Andleeb S; Burnham CA; Dantas G Emerg Infect Dis; 2015 Jun; 21(6):1034-7. PubMed ID: 25988236 [TBL] [Abstract][Full Text] [Related]
7. Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams? Canoui E; Tankovic J; Bige N; Alves M; Offenstadt G Med Mal Infect; 2014 May; 44(5):235-7. PubMed ID: 24780641 [No Abstract] [Full Text] [Related]
8. Effect of Meropenem Concentration on the Detection of Low Numbers of Carbapenem-Resistant Enterobacteriaceae. Tanner WD; Atkinson RM; Goel RK; Porucznik CA; Benson LS; VanDerslice JA Antimicrob Agents Chemother; 2016 Jan; 60(1):712-3. PubMed ID: 26552977 [No Abstract] [Full Text] [Related]
9. Future alternatives for the treatment of infections caused by carbapenemase-producing Enterobacteriaceae: what is in the pipeline? Horcajada JP; Torre-Cisneros J; Peña C; Fariñas MC Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():56-60. PubMed ID: 25542053 [TBL] [Abstract][Full Text] [Related]
10. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era? Pascual Á; Pintado V; Rodríguez-Baño J; Miró JM Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045 [TBL] [Abstract][Full Text] [Related]
11. Low Frequency of Ceftazidime-Avibactam Resistance among Enterobacteriaceae Isolates Carrying Castanheira M; Mendes RE; Sader HS Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031200 [No Abstract] [Full Text] [Related]
12. CTX-M and plasmid-mediated AmpC-producing Enterobacteriaceae Singapore. Koh TH; Wang GC; Sng LH; Koh TY Emerg Infect Dis; 2004 Jun; 10(6):1172-4. PubMed ID: 15224678 [No Abstract] [Full Text] [Related]
13. New broad-spectrum β-lactamases emerging among Enterobacteriaceae from healthy cats and dogs: a public health concern? Smet A; Vaes R; Praud K; Doublet B; Daminet S; Cloeckaert A; Haesebrouck F Int J Antimicrob Agents; 2014 Jul; 44(1):81-2. PubMed ID: 24916079 [No Abstract] [Full Text] [Related]
15. Epidemiology and antimicrobial susceptibility profiles of Enterobacterales causing bloodstream infections before and during COVID-19 pandemic: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) in Taiwan, 2018-2021. Lee YL; Liu CE; Tang HJ; Huang YT; Chen YS; Hsueh PR; J Microbiol Immunol Infect; 2024 Jun; 57(3):446-456. PubMed ID: 38632023 [TBL] [Abstract][Full Text] [Related]
16. Identification of Enterobacteriaceae isolates with OXA-48 and coproduction of OXA-181 and NDM-1 in Norway. Samuelsen Ø; Naseer U; Karah N; Lindemann PC; Kanestrøm A; Leegaard TM; Sundsfjord A J Antimicrob Chemother; 2013 Jul; 68(7):1682-5. PubMed ID: 23463214 [No Abstract] [Full Text] [Related]
17. Carbapenemase-producing enterobacteriaceae (CPE) in the pediatric setting: results from an 18-month survey. Colombo S; Scolfaro C; Calitri C; Denina M; Carraro F; De Intinis G; Tovo PA Infect Control Hosp Epidemiol; 2014 May; 35(5):599-601. PubMed ID: 24709738 [No Abstract] [Full Text] [Related]
18. Multiresistant Enterobacteriaceae: new threat of an old problem. Pitout JD Expert Rev Anti Infect Ther; 2008 Oct; 6(5):657-69. PubMed ID: 18847404 [TBL] [Abstract][Full Text] [Related]
19. Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings. Bou G; Vila J; Seral C; Castillo FJ Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():24-32. PubMed ID: 25542049 [TBL] [Abstract][Full Text] [Related]
20. Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART). Sheng WH; Badal RE; Hsueh PR; Antimicrob Agents Chemother; 2013 Jul; 57(7):2981-8. PubMed ID: 23587958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]